9c4l
From Proteopedia
(Difference between revisions)
m (Protected "9c4l" [edit=sysop:move=sysop]) |
|||
| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal structure of mutant NonPro1 Tautomerase Superfamily Member NJ7-V1P in complex with 3-bromopropiolate inhibitor== | |
| + | <StructureSection load='9c4l' size='340' side='right'caption='[[9c4l]], [[Resolution|resolution]] 2.09Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[9c4l]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Nostoc_sp. Nostoc sp.]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9C4L OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9C4L FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.09Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1AWY:3-bromanyl-3-oxidanylidene-propanoic+acid'>A1AWY</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9c4l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9c4l OCA], [https://pdbe.org/9c4l PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9c4l RCSB], [https://www.ebi.ac.uk/pdbsum/9c4l PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9c4l ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/Q8YNJ7_NOSS1 Q8YNJ7_NOSS1] | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Pro1 is a critical catalytic residue in the characterized activities of tautomerase superfamily (TSF) members. Only a handful of members ( approximately 346) lack Pro1 in a sequence similarity network (SSN) that consists of over 11,000 members. Most (294 members) are in the malonate semialdehyde decarboxylase (MSAD)-like subgroup, but the ones characterized thus far have little or no MSAD activity. Moreover, there is little to no activity with other TSF substrates. Five non-Pro1 members were selected randomly for kinetic [using phenylenolpyruvate (PP) and 2-hydroxymuconate (2HM)], mutagenic, inhibition, and crystallographic analysis. Using PP, k(cat)/K(m) values ( approximately 10(1)-10(2) M(-1) s(-1)) could be estimated for three native proteins whereas using 2HM, a k(cat)/K(m) value could only be estimated for one native protein ( approximately 10(3) M(-1) s(-1)). The k(cat) and K(m) values could not be determined. However, changing the N-terminal residue to a proline gave a significant improvement in k(cat)/K(m) values for all mutant enzymes using PP or 2HM. For PP, the k(cat)/K(m) values ranged from 10(3)-10(5) M(-1) s(-1) and for 2HM, the k(cat)/K(m) values ranged from 10(2)-10(4) M(-1) s(-1). In addition, it was now possible to measure k(cat) and K(m) values for all mutant proteins using PP and one mutant protein using 2HM. Incubation of the Pro1 mutants with 3-bromopropiolate (3BP) results in covalent modification of the prolyl nitrogen of Pro1 by a 3-oxopropanoate adduct. Crystallographic analysis of two mutant enzymes (NJ7V1P and 8U6S1P) modified by the 3-oxopropanoate adduct identified binding ligands and suggest a mechanism for the tautomerase activity involving Pro1, Arg71, Tyr124, and the backbone amide of Phe68. | ||
| - | + | Conversion of Inactive Non-Pro1 Tautomerase Superfamily Members into Active Tautomerases: Analysis of the Pro1 Mutants.,Lancaster EB, Hardtke HA, Melkonian TR, Venkat Ramani M, Johnson WH Jr, Baas BJ, Zhang YJ, Whitman CP Biochemistry. 2025 Feb 18;64(4):812-822. doi: 10.1021/acs.biochem.4c00338. Epub , 2025 Feb 6. PMID:39914393<ref>PMID:39914393</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | <div class="pdbe-citations 9c4l" style="background-color:#fffaf0;"></div> | |
| - | + | == References == | |
| - | + | <references/> | |
| - | + | __TOC__ | |
| - | [[Category: | + | </StructureSection> |
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Nostoc sp]] |
| - | [[Category: Venkat Ramani | + | [[Category: Hardtke HA]] |
| - | [[Category: | + | [[Category: Venkat Ramani MK]] |
| + | [[Category: Zhang YJ]] | ||
Current revision
Crystal structure of mutant NonPro1 Tautomerase Superfamily Member NJ7-V1P in complex with 3-bromopropiolate inhibitor
| |||||||||||
